Jordan Lee Huffman, PT, DPT Physical Medicine & Rehabilitation - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 134 E Bloomingdale Ave, Brandon, FL 33511 Phone: 813-681-1627 |
Molly Kaleen Kimball, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 721 W Robertson St Ste 102, Brandon, FL 33511 Phone: 862-676-8502 |
Jessica G Cupido, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2020 Town Center Blvd Ste D, Brandon, FL 33511 Phone: 813-284-2212 Fax: 813-377-1713 |
Dr. Amit Kishore Patel, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1465 Oakfield Dr, Brandon, FL 33511 Phone: 813-655-0404 Fax: 813-635-9589 |
News Archive
A Complaint and Consent Decree of Permanent Injunction were filed Wednesday, August 8 in the U.S. District Court for the Northern District of Iowa, Western Division, against Ysselstein Dairy Inc., Rock Valley, Iowa, and its owner and president, Sjerp W. Ysselstein, after illegal drug residues were found in the dairy's cows.
Amyloid diseases, including Alzheimer's, Parkinson's, type-2 diabetes and other life-threatening diseases, involve pathologic deposits of normally soluble proteins or peptides as insoluble amyloid fibrils. When this happens in vital organs, such as the brain, kidney, liver and heart, it causes organ damage and, if left untreated, death. Unfortunately, the available treatment options are very limited.
Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.
Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.
› Verified 2 days ago